| Metric | შპს ივერმედი | შპს დენკ ფარმა კავკასია |
|---|---|---|
| Growth | ||
| Revenue | ₾45.9m₾47.1m | ₾22.1m₾20.5m |
| Revenue growth | -2.5% | 7.7% |
| Profitability | ||
| EBITDA | -₾1.1m₾3.1m | ₾2.4m₾833k |
| EBITDA margin | -2.4%6.6% | 10.7%4.1% |
| Net profit | -₾993k₾4.4m | ₾1.4m₾589k |
| Net margin | -2.2%9.3% | 6.4%2.9% |
| Balance sheet | ||
| Total assets | ₾38.9m₾42.4m | ₾13.2m₾11.6m |
| Total equity | ₾30.8m₾35.6m | ₾4.6m₾4.7m |
| ROE | -3.2%12.3% | 30.4%12.5% |